| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 140 |
| 1 | LEFLUNOMIDE | 139 |
| 2 | ETANERCEPT | 138 |
| 3 | ABATACEPT | 124 |
| 4 | TOCILIZUMAB | 123 |
| 5 | METHOTREXATE | 122 |
| 6 | TOFACITINIB | 109 |
| 7 | HYDROXYCHLOROQUINE SULFATE | 96 |
| 8 | INFLIXIMAB | 86 |
| 9 | SULFASALAZINE | 85 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GOLD | 61 | 0.0172 |
| 1 | ELETRIPTAN HYDROBROMIDE | 22 | 0.0033 |
| 2 | LEFLUNOMIDE | 139 | 0.0019 |
| 3 | TOCILIZUMAB | 123 | 0.0019 |
| 4 | SULFASALAZINE | 85 | 0.0017 |
| 5 | HYDROXYCHLOROQUINE SULFATE | 96 | 0.0015 |
| 6 | ABATACEPT | 124 | 0.0014 |
| 7 | CIDOFOVIR ANHYDROUS | 1 | 0.0012 |
| 8 | PROBENECID | 1 | 0.0011 |
| 9 | TOFACITINIB | 109 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 149 |
| 1 | Antirheumatic Agent [EPC] | 139 |
| 2 | Selective T Cell Costimulation Modulator [EPC] | 124 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 123 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 122 |
| 5 | Aminosalicylate [EPC] | 85 |
| 6 | Standardized Chemical Allergen [EPC] | 61 |
| 7 | Corticosteroid [EPC] | 41 |
| 8 | Purine Antimetabolite [EPC] | 38 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 33 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Standardized Chemical Allergen [EPC] | 61 | 0.0059 |
| 1 | Antirheumatic Agent [EPC] | 139 | 0.0019 |
| 2 | Interleukin-6 Receptor Antagonist [EPC] | 123 | 0.0017 |
| 3 | Selective T Cell Costimulation Modulator [EPC] | 124 | 0.0014 |
| 4 | Aminosalicylate [EPC] | 85 | 0.0010 |
| 5 | Purine Antimetabolite [EPC] | 38 | 0.0006 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 122 | 0.0004 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 149 | 0.0002 |
| 8 | Xanthine Oxidase Inhibitor [EPC] | 16 | 0.0001 |
| 9 | Tetracycline-class Drug [EPC] | 5 | 0.0001 |